Cargando…
Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer
The insulin-like growth factor-1 receptor (IGF1R) emerged in recent years as a promising therapeutic target in oncology. Identification of potential biomarkers capable of predicting response to IGF1R-targeted therapy is of cardinal importance. Tumor suppressor BRCA1 has important roles in multiple p...
Autores principales: | Cohen-Sinai, Tali, Cohen, Zoya, Werner, Haim, Berger, Raanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489552/ https://www.ncbi.nlm.nih.gov/pubmed/28706506 http://dx.doi.org/10.3389/fendo.2017.00148 |
Ejemplares similares
-
Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients
por: Sinai-Livne, Tali, et al.
Publicado: (2020) -
Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns
por: Sarfstein, Rive, et al.
Publicado: (2020) -
BRCA1: An Endocrine and Metabolic Regulator
por: Werner, Haim
Publicado: (2022) -
Insulin-like growth factors and aging: lessons from Laron syndrome
por: Werner, Haim, et al.
Publicado: (2023) -
All-Atom Structural Models of the Transmembrane Domains of Insulin and Type 1 Insulin-Like Growth Factor Receptors
por: Mohammadiarani, Hossein, et al.
Publicado: (2016)